Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments
D. Fuchs(Uppsala University), Faranak Azarbayjani(Uppsala University)
Cited by 8
Related Papers
The Anti-VEGF Antibody Bevacizumab Potently Reduces the Growth Rate of High-Risk Neuroblastoma Xenografts
|Pediatric Research|2006|96